Clinical Trials Logo

Filter by:
NCT ID: NCT02682940 Terminated - Clinical trials for Diabetes Mellitus, Type 1

T1 Diabetes Hypoglycemia Prevention Pilot

Start date: May 2016
Phase: N/A
Study type: Interventional

A single center pilot study assessing the Vigilant Diabetes Management System for the prevention of recurrent mild to moderate hypoglycemia in type I diabetes patients.

NCT ID: NCT02681809 Terminated - Clinical trials for Diabetic Retinopathy

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

CIRCLE
Start date: December 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of up to 3 intravitreal injections of ocriplasmin (0.0625mg or 0.125mg), in subjects with moderate to very severe non-proliferative diabetic retinopathy (NPDR), to induce total posterior vitreous detachment (PVD) in order to reduce the risk of disease progression to proliferative diabetic retinopathy (PDR).

NCT ID: NCT02681601 Terminated - Cancer of Pancreas Clinical Trials

Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer

Start date: July 19, 2016
Phase: N/A
Study type: Interventional

There are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia. The aim of this study is to examine the effect of dietary prescription with and without nutrition supplementation in patients with unresectable pancreatic cancer on body weight, body composition, total calorie intake, quality of life and blood inflammatory markers.

NCT ID: NCT02681419 Terminated - Glaucoma Clinical Trials

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

Start date: January 2013
Phase: Phase 4
Study type: Interventional

This study evaluates two different methods of controlling intraocular pressure in nonvalved aqueous tube shunts immediately after implantation; needle fenestrations or a suture wick.

NCT ID: NCT02681302 Terminated - Multiple Myeloma Clinical Trials

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence

CPIT001
Start date: June 7, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to determine the safety and clinical effect of combined checkpoint inhibition administered after autologous hematopoietic stem cell transplantation in each of six clinical cohorts of high risk and recurrent disease. In addition to assessing the incidence and severity of adverse events and rates of complete response and progression free survival, investigators intend to monitor immune reconstitution, phenotype and TCR repertoire throughout treatment and at the time of disease progression. Investigators will also analyze the gut microbiome prior to conditioning, throughout treatment, post-transplant and at time of relapse.

NCT ID: NCT02680847 Terminated - Clinical trials for Moderate-severe Pain

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Start date: January 21, 2016
Phase: Phase 4
Study type: Interventional

Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of oxycodone hydrochloride with a sequestered naltrexone core in children 7-17 with moderate-severe pain.

NCT ID: NCT02680834 Terminated - Venous Leg Ulcer Clinical Trials

VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to test non-inferiority of chronic Venous Leg Ulcer (VLU) area reduction at 16 weeks with a dual action pneumatic compression device compared to multi-layer bandaging.

NCT ID: NCT02680782 Terminated - Healthy Clinical Trials

A Study Comparing Once-Daily vs. Twice-Daily Dosing of X4P-001 in Healthy Volunteers

Start date: January 12, 2016
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability and pharmacokinetics of X4P-001 administered as 200 mg twice daily compared with 400 mg once daily. This study will also assess the pharmacodynamic effects of X4P-001 administered as 200 mg twice daily compared with 400 mg once daily on levels of circulating white blood cells (total and by cell type).

NCT ID: NCT02680704 Terminated - Critical Illness Clinical Trials

Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to collect physiologic data from patients with severe brain injury who require mechanical ventilation in order to describe the impact of ventilation, specifically positive end expiratory pressure (PEEP), on intracranial pressure (ICP).

NCT ID: NCT02680639 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants

Start date: November 13, 2015
Phase: N/A
Study type: Interventional

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality throughout the world, being the fourth leading cause of death in the world. This study is designed to detect COPD participants with Expiratory Flow Limitation. EFL occurs when the airways become compressed which usually results when a pressure outside the airway exceeds the pressure inside the airway. Participants will undergo study eligibility procedures at visit 1. At visit 2 participants will undergo a baseline auto-EPAP (Expiratory Positive Airway Pressure) measurement. Then the order will be randomized to three different treatment methods. Between each treatment there will be at least a 10 minute washout period in order for CO2 to stabilize and return to baseline.